Olema Pharmaceuticals Inc.
OLMA | NASDAQ
$9.64
-$0.18 (-1.83%)
At close: Sep 21, 2026, 4:00 PM ET
$9.74
+$0.10 (+1.04%)
After-hours:
Sep 21, 2026, 7:43 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -13.37 | -2.65 | -6.56 | -0.94 | -5.23 | -82.90 |
PEG Ratio | 0.89 | -0.95 | 0.36 | -0.02 | -0.03 | -0.19 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 4.55 | 0.84 | 2.50 | 0.50 | 1.30 | 5.59 |
P/FCF Ratio | -14.83 | -3.28 | -7.58 | -1.19 | -7.08 | -94.87 |
P/OCF Ratio | -14.83 | -3.28 | -7.58 | -1.19 | -7.30 | -95.13 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0 | 0 | 0.01 | 0.01 | 0.01 | n/a |
Quick Ratio | 9.95 | 10.50 | 12.33 | 12.62 | 32.23 | 74.62 |
Current Ratio | 9.95 | 10.50 | 12.33 | 12.62 | 32.23 | 74.62 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | -32.97 |
Return on Equity | -33.95% | -31.66% | -38.07% | -53.04% | -24.98% | -6.54% |
Return on Assets | -30.45% | -28.71% | -34.90% | -48.59% | -24.02% | -6.45% |
Return on Invested Capital | -37.02% | -34.66% | -40.95% | -53.46% | -24.84% | -6.37% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove OLMA